Today we reached a settlement agreement w/ @AstraZeneca.
This includes a binding commitment to deliver all #COVID19 vaccines under our contract.
We are pleased to have found a mutually satisfactory solution that benefits 🇪🇺citizens & 🌍 citizens via our global COVAX commitment.
Meet the most innovative #cellandgenetherapy developers and committed regulators and policy makers at @EuropaBio series of webinars to discuss the future of # #healthcare
Kick-off on 11 May!
We have just launched EuropaBio Advanced Therapies Series. 🥳💥
📍The first event under the title ‘Taking health up a gear: value of advanced therapies’ will take place on May 11, from 12h00 to 13h00 (CEST). Register here: https://t.co/jJuNQ7wbQX
Are you coming?🤔
❗ We are launching a joint letter showing the cancer community's willingness to support governments in their effort to help cancer patients globally! Thanks to the 292 cancer stakeholders that have supported the initiative #COVID19andCancer
➡️https://t.co/13BX66yHQD
Delighted to share our work with @WS_Brussels @cancereu @EUneurology @spietikainen & @EuropaBio on campaigning #PatientEmpowerment 👏👏👏
Shall we systematically and meaningfully involve patients in the entire innovative #medicine lifecycle!
📢 WE ARE #HIRING!
@EuropaBio is looking for a new #intern to join the #Healthcare#Biotechnology Team!
For more information about the role, and how to apply, check out our website: https://t.co/gQZI3sVDkS
#RareDiseaseDay2021
So much more knowledge, investment & collaborations are needed. #Biotechnology#innovations should be further supported to fill the gaps bn rare & regular
Only medical innovation can stem the devastating cost of #COVID19. Fostering a research eco-system that can deliver innovation rather than undermining it through challenges to IP is the best way to protect people https://t.co/SG1tHWy19u #WeWontRest
Learn about the economic footprint of one of the 🇪🇺 most innovative & research-intensive industries with @EuropaBio & @WifOR_Institute on March 4
#Europe’s Biotech #Boost: €78bn and 900,000 #Jobs! 🧬
Discover the ‘Economic Footprint of the #Biotechnology Industry in Europe’! ➡️ https://t.co/k4vdVVAkxv 🧬
Join us on March 4th to find out more! ➡️ https://t.co/k2zLDFedDS 🧬
Encouraged by @EU_Health's recognition of new technologies & highly personalised advanced therapies as a "powerful tool" of the future of cancer treatment in #EUCancerPlan today @EuropaBio
Advanced #cancer treatments require an environment that is supportive of #healthcare innovation, and the #EUCancerPlan is a critical instrument for ensuring that. @EuropaBio fully supports the @EU_Commission's "all hands on deck" approach against cancer. @GrimmBj
As we are eagerly waiting for #EUCancerPlan this week #DYK cell therapy has advanced most in #oncology - 665 out of all 1,078 clinical trials with advanced therapies globally (as of H1 2020) were in #oncology@EU_Health @EP_BeatCancer @cancereu